TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Adesso Bioproducts AS
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
85,690
|
105,368
|
74,976 |
| Financial expenses |
1,084
|
604
|
355 |
| Earnings before taxes |
4,824
|
6,683
|
5,055 |
| Total assets |
66,310
|
80,634
|
81,184 |
| Current assets |
49,780
|
64,506
|
64,318 |
| Current liabilities |
24,003
|
42,012
|
47,689 |
| Equity capital |
41,605
|
37,847
|
32,641 |
| - share capital |
103
|
103
|
103 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
62.7%
|
46.9%
|
40.2% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
5.6%
|
6.3%
|
6.7% |
| Return on assets (ROA) |
8.9%
|
9.0%
|
6.7% |
| Current ratio |
207.4%
|
153.5%
|
134.9% |
| Return on equity (ROE) |
11.6%
|
17.7%
|
15.5% |
| Change turnover |
-19,678
|
30,392
|
15,797 |
| Change turnover % |
-19%
|
41%
|
27% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.